USP24
Disease associated variation - GWASdb
ChrPosSNP ID(dbSNP 142)RefAltOri SNP IDP-valueDrug NameDrug AnnoGWAS TraitHPO IDDO IDAATypeTrait or Drug
155546696rs17111584TCrs171115845.80E-04ROSUVASTATINFLUOROBENZENES|CHOLESTEROL, LDL|PYRIMIDINES|SULFONAMIDES|ANTICHOLESTEREMIC AGENTSResponse to statin therapy (LDL-C)HPOID:0001677DOID:3393|DOID:1936TintronGWASdb_drug
155590465rs17111652CTrs171116529.36E-05HYDROCHLOROTHIAZIDE|CANDESARTANEPITHELIAL SODIUM CHANNELS|DIURETICS|ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS|BENZIMIDAZOLES|GPR83 PROTEIN, HUMAN|TETRAZOLES|RECEPTORS, G-PROTEIN-COUPLED|SCNN1G PROTEIN, HUMANResponse to angiotensin II receptor blocker therapy (opposite direction w/ diuretic therapy)HPOID:0000847DOID:10763CintronGWASdb_drug
155537198rs17111568GArs171115681.74E-04Multiple complex diseasesHPOID:0000118NAGintronGWASdb_trait
155546696rs17111584TCrs171115845.80E-04Response to statin therapy (LDL-C)HPOID:0001677DOID:3393|DOID:1936TintronGWASdb_trait
155546895rs683880TCrs6838805.67E-04Substance dependenceHPOID:0000707DOID:9973TintronGWASdb_trait
155590465rs17111652CTrs171116529.36E-05Response to angiotensin II receptor blocker therapy (opposite direction w/ diuretic therapy)HPOID:0000847DOID:10763CintronGWASdb_trait
155591283rs17111657CArs171116578.89E-04Suicide attempts in bipolar disorderHPOID:0007302DOID:3312AintronGWASdb_trait
155625548rs17111684CTrs171116842.00E-17LDL cholesterolHPOID:0010979DOID:1936|DOID:3393CintronGWASdb_trait
155627525rs17111689CGrs171116895.07E-04Suicide attempts in bipolar disorderHPOID:0007302DOID:3312CintronGWASdb_trait
155653588rs1115058CTrs11150588.79E-04Suicide attempts in bipolar disorderHPOID:0007302DOID:3312GintronGWASdb_trait
155662680rs4926670CTrs49266703.07E-05LDL lipoproteinsHPOID:0003119|HPOID:0002621DOID:1936CintronGWASdb_trait
155670896rs6671533GCrs66715333.94E-04Suicide attempts in bipolar disorderHPOID:0007302DOID:3312GintronGWASdb_trait
155673420rs6703366TGrs67033666.08E-04Suicide attempts in bipolar disorderHPOID:0007302DOID:3312TintronGWASdb_trait
Disease associated variation - GWAS Central
Study NameSource Marker AccessionChromosomeMarker StartMarker StopAllelesGene SectionP-value-log(p-value)
GWAS of prostate cancerrs116523715559921955599219intronic0.9556710.0196915925316486
GWAS of prostate cancerrs670336615567342055673420intronic0.9458320.0241859967402109
GWAS of prostate cancerrs49715915555355455553554intronic0.9442310.0249217453706261
GWAS of prostate cancerrs116522215563807555638075exonic0.9401650.0267959205481043
GWAS of prostate cancerrs492667015566268055662680intronic0.792180.10117612633374899
GWAS of prostate cancerrs1213079915566337255663372intronic0.7597180.119347583733841
GWAS of prostate cancerrs1711158415554669655546696intronic0.3108020.507516195192329
GWAS of prostate cancerrs28723415566652055666520intronic0.2558120.592079086864613
GWAS of prostate cancerrs116528415555706755557067intronic0.2145280.668516016057874
GWAS of prostate cancerrs48723015554117455541174exonic0.1880090.7258213605406709
GWAS of prostate cancerrs102430515563020455630204intronic0.1867510.728737063979396
GWAS of prostate cancerrs116522115563762055637620intronic0.1859240.7306645457052081
GWAS of prostate cancerrs116523815564600655646006intronic0.1758640.754823053103478
GWAS of prostate cancerrs116522615560800555608005intronic0.1731960.761462142330149
GWAS of prostate cancerrs1711165215559046555590465intronic0.1257210.9005921732100199
Disease associated variation - OMIM
Ensembl_gene_ID Approved Gene Symbol MIM Number
ENSG00000162402.13 USP24 610569